# Remote Ischemic Conditioning for the Treatment of Diabetic Kidney Disease

> **NCT06654921** · NA · NOT_YET_RECRUITING · sponsor: **Capital Medical University** · enrollment: 60 (estimated)

## Conditions studied

- Diabetic Kidney Disease (DKD)

## Interventions

- **DEVICE:** Remote ischemic conditioning
- **DEVICE:** Sham remote ischemic conditioning
- **DRUG:** Standard medication therapy

## Key facts

- **NCT ID:** NCT06654921
- **Lead sponsor:** Capital Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06654921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06654921, "Remote Ischemic Conditioning for the Treatment of Diabetic Kidney Disease". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06654921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*